Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II Trial

Q. Xiong, Henry; Rosenberg, Arthur; F. LoBuglio, Albert; Schmidt, William; A. Wolff, Robert; C. Deutsch, John; N. Needle, Michael; L. Abbruzzese, James

doi:10.1200/jco.2004.12.040

Public

Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II Trial

Published in Journal of Clinical Oncology • Jun 28, 2004

Authors:

Henry Q. Xiong

Arthur Rosenberg

Albert F. LoBuglio

Abstract

PURPOSE: To determine the response rate, time to disease progression, survival duration and rate, and toxicity with the combination of cetuximab and gemcitabine in patients with epidermal growth factor receptor (EGFR)-expressing advanced pancreatic cancer. PATIENTS AND METHODS: Patients with measura...

Subject

Cetuximab

Medicine

Gemcitabine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!